Back to Results
First PageMeta Content
Business / Thermo Fisher Scientific / Forward-looking statement / Biopharmaceutical / Technology / Research / Biotechnology / Pharmacology / Life Technologies


RepliGen Repligen Corporation 41 Seyon Street Building #1, Suite 100 Waltham, Massachusetts 02453
Add to Reading List

Document Date: 2014-06-12 09:52:45


Open Document

File Size: 118,55 KB

Share Result on Facebook

City

Lund / Waltham / Paris / /

Company

Merck & Co. Inc. / RepliGen Repligen Corporation / Life Technologies / Vaccine Technology / Biogen Idec / Thermo Fisher Scientific Corporation / Repligen Corporation / Cells Systems / /

Continent

Asia / Europe / /

Country

United States / Sweden / /

Currency

USD / /

Event

M&A / /

Facility

Seyon Street Building / University of California / /

IndustryTerm

biologic drug manufacturing / biopharmaceutical / biopharmaceutical industry veteran / value consumable products / purification media / supply chain management / bioprocessing products / manufacturing facilities / biopharmaceutical manufacturers / biopharmaceutical customers / growth factor products / filtration devices / manufacturing organization / /

Organization

Ecole Supérieure de Physique / University of California / Berkeley / Board of Directors WALTHAM / /

Person

Walter C. Herlihy / Nicolas M. Barthelemy / /

/

Position

Project Engineer / President / Global Commercial Operations / Vice President / Manufacturing and General Manager for the company / President and Chief Executive Officer / director role / President / Global Commercial / /

ProvinceOrState

California / Massachusetts / /

Technology

bioprocessing / /

SocialTag